Our Solutions
State of the art performance to deliver clinical value
Our experienced clinicians, data scientists and regulatory experts are working together to bring research into practice.
// ANTIMICROBIAL RESISTANCE
Getting Antibiotics Right
Our first product is focused on tackling variation in antibiotic prescribing across the NHS, with benefits to patients, healthcare costs and societal impact of AMR.
Antimicrobial resistance is a global health threat with projections of 10 million deaths and cost $100 trillion by 2050. In the UK, AMR has been defended as a national health priority in the NHS Long Term Plan.
// SUPPORTING PRESCRIBING
Next Generation Clinical Support
Abtrace has developed a next generation decision support tool; underpinned by cutting edge Natural Language Processing (NLP) and developed with expert clinical insight. We have already achieved performance equivalent to clinicians in terms of accuracy for antibiotic prescription related questions.
This tool helps doctors make the most appropriate decisions regarding antibiotics, when to use them and which antibiotic to use. This increased precision will reduce the misuse of antibiotics, saving costs and saving lives.
// EXPANDING CLINICAL APPLICATIONS
Unlocking Unstructured Data
Responding to clinicians, we are expanding our clinical focus deriving insights to inform decision making around investigations, diagnosis and referrals. We are building clinical partnerships in multiple settings including:
General Practice
Emergency Departments
Intensive Care
Our Solutions
State of the art performance to deliver clinical value
Our experienced clinicians, data scientists and regulatory experts are working together to bring research into practice.
// ANTIMICROBIAL RESISTANCE
Getting Antibiotics Right
Our first product is focused on tackling variation in antibiotic prescribing across the NHS, with benefits to patients, healthcare costs and societal impact of AMR.
Antimicrobial resistance is a global health threat with projections of 10 million deaths and cost $100 trillion by 2050. In the UK, AMR has been defended as a national health priority in the NHS Long Term Plan.
// SUPPORTING PRESCRIBING
Next Generation Clinical Support
Abtrace has developed a next generation decision support tool; underpinned by cutting edge Natural Language Processing (NLP) and developed with expert clinical insight. We have already achieved performance equivalent to clinicians in terms of accuracy for antibiotic prescription related questions.
This tool helps doctors make the most appropriate decisions regarding antibiotics, when to use them and which antibiotic to use. This increased precision will reduce the misuse of antibiotics, saving costs and saving lives.
// EXPANDING CLINICAL APPLICATIONS
Unlocking Unstructured Data
Responding to clinicians, we are expanding our clinical focus deriving insights to inform decision making around investigations, diagnosis and referrals. We are building clinical partnerships in multiple settings including:
General Practice
Emergency Departments
